Dollar cost averaging (DCA) in MLYS means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More MLYS Analysis
MLYS DCA Calculator
Dollar Cost Averaging — Mineralys Therapeutics, Inc.
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return+114.2%
Final Value$62.1K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return+96.1%
Final Value$56.9K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return+81.4%
Final Value$52.6K
Worst possible — still beats not investing
Best vs Worst gap32.8 pp
Your timing vs best-18.1%
Your timing vs worst+14.7%
If You Keep Investing…
Based on this stock's historical CAGR of 23.2%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$25K~1.4x your moneyfrom $18K invested
5 Years$52K~1.7x your moneyfrom $30K invested
10 Years$201K~3.3x your moneyfrom $60K invested
20 Years$1.8M~15.1x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.4x your money
5 Years~1.7x your money
10 Years~3.3x your money
20 Years~15.1x your money
$100/mo
$5K+$1K est. gain
$10K+$4K est. gain
$40K+$28K est. gain
$362K+$338K est. gain
$250/mo
$12K+$3K est. gain
$26K+$11K est. gain
$100K+$70K est. gain
$906K+$846K est. gain
$500/mo
$25K+$7K est. gain
$52K+$22K est. gain
$201K+$141K est. gain
$1.8M+$1.7M est. gain
$1,000/mo
$50K+$14K est. gain
$105K+$45K est. gain
$401K+$281K est. gain
$3.6M+$3.4M est. gain
* Projection assumes historical CAGR of 23.2% continues. Actual returns will vary.
Your DCA Results by Date
39 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Feb 10, 2023
$18.44
$10,000
$10,000
+0.00%
$0
Mar 10, 2023
$16.28
$10,500
$9,329
-11.16%
$-1,171
Apr 10, 2023
$14.67
$11,000
$8,906
-19.04%
$-2,094
May 10, 2023
$16.10
$11,500
$10,274
-10.66%
$-1,226
Jul 19, 2023
$14.99
$12,000
$10,066
-16.12%
$-1,934
Jul 19, 2023
$14.99
$12,500
$10,566
-15.47%
$-1,934
Aug 10, 2023
$13.12
$13,000
$9,748
-25.02%
$-3,252
Sep 11, 2023
$12.00
$13,500
$9,416
-30.25%
$-4,084
Oct 10, 2023
$9.69
$14,000
$8,103
-42.12%
$-5,897
Nov 10, 2023
$6.45
$14,500
$5,894
-59.35%
$-8,606
Dec 11, 2023
$7.02
$15,000
$6,915
-53.90%
$-8,085
Jan 10, 2024
$9.23
$15,500
$9,591
-38.12%
$-5,909
Feb 12, 2024
$14.72
$16,000
$15,796
-1.27%
$-204
Mar 11, 2024
$13.26
$16,500
$14,730
-10.73%
$-1,770
Apr 10, 2024
$12.84
$17,000
$14,763
-13.16%
$-2,237
May 10, 2024
$13.52
$17,500
$16,045
-8.31%
$-1,455
Jun 10, 2024
$13.50
$18,000
$16,521
-8.22%
$-1,479
Jul 10, 2024
$13.10
$18,500
$16,532
-10.64%
$-1,968
Aug 12, 2024
$11.34
$19,000
$14,811
-22.05%
$-4,189
Sep 10, 2024
$12.01
$19,500
$16,186
-17.00%
$-3,314
Oct 10, 2024
$13.42
$20,000
$18,586
-7.07%
$-1,414
Nov 11, 2024
$14.92
$20,500
$21,163
+3.24%
$663
Dec 10, 2024
$13.14
$21,000
$19,138
-8.86%
$-1,862
Jan 10, 2025
$9.87
$21,500
$14,876
-30.81%
$-6,624
Feb 10, 2025
$9.51
$22,000
$14,833
-32.58%
$-7,167
Page 1 of 2
Frequently Asked Questions
Common questions about DCA investing in MLYS
Investing $500 per month in Mineralys Therapeutics, Inc. (MLYS) over the past 3 years would be worth approximately $57K today. That's +96.1% total return on $29K invested, with a +23.2% compound annual growth rate (CAGR).